No Data
No Data
BeiGene Slips on Decision to Halt Lung Cancer Program
Compugen to Participate in Multiple Virtual Investor Conferences in April 2025
Calculating The Intrinsic Value Of Compugen Ltd. (NASDAQ:CGEN)
Truist Financial Maintains Compugen(CGEN.US) With Buy Rating
Compugen Ltd. (NASDAQ:CGEN) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
Compugen's 2024 Results Highlight Clinical Progress and Financial Stability